EY4-32832-23697
3 vaccinations
3 coded responses
19 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 965
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3PR-12740-45840
Child or adolescent in my care · Female · 2022-01-09
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-07
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-08
- 2021-02-13
- 2021-02-20
-
2021-04-10
Survey response — 3 months, dose 2MedDRA: Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-12
-
2021-11-30
Dose 3 — Pfizer-BioNTech
- 2022-01-09
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: Tinnitus, Vertigo — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tinnitus with episodes of vertigo.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-02-10
-
2022-03-01
Survey response — 3 months, dose 3MedDRA: Acupuncture, Menstruation irregular, Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Tinnitus, irregular periods · Healthcare visit (other): AcupunctureMedDRA releases: 2024-11 · check-in free text available
-
2022-03-01
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — 3 months, dose 2
Symptoms: Tinnitus
Release 10 — 12 months, dose 2
Symptoms: Tinnitus with episodes of vertigo.
Release 11 — 3 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Acupuncture | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release